Your browser doesn't support javascript.
loading
Prevalence of dementia subtypes in United States Medicare fee-for-service beneficiaries, 2011-2013.
Goodman, Richard A; Lochner, Kimberly A; Thambisetty, Madhav; Wingo, Thomas S; Posner, Samuel F; Ling, Shari M.
Afiliação
  • Goodman RA; National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Prevention and Control, Atlanta, GA, USA; Department of Family and Preventive Medicine, Emory University School of Medicine, Atlanta, GA, USA. Electronic address: rgood02@emory.edu.
  • Lochner KA; Centers for Medicare & Medicaid Services, Baltimore, MD, USA.
  • Thambisetty M; Clinical and Translational Neuroscience Unit, Laboratory of Behavioral Neuroscience, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA.
  • Wingo TS; Department of Neurology and Human Genetics, Emory University School of Medicine, Atlanta, GA, USA; Division of Neurology, Atlanta VA Medical Center, Atlanta, GA, USA.
  • Posner SF; National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Prevention and Control, Atlanta, GA, USA.
  • Ling SM; Centers for Medicare & Medicaid Services, Baltimore, MD, USA.
Alzheimers Dement ; 13(1): 28-37, 2017 01.
Article em En | MEDLINE | ID: mdl-27172148
ABSTRACT

INTRODUCTION:

Rapid growth of the older adult population requires greater epidemiologic characterization of dementia. We developed national prevalence estimates of diagnosed dementia and subtypes in the highest risk United States (US) population.

METHODS:

We analyzed Centers for Medicare & Medicaid administrative enrollment and claims data for 100% of Medicare fee-for-service beneficiaries enrolled during 2011-2013 and age ≥68 years as of December 31, 2013 (n = 21.6 million).

RESULTS:

Over 3.1 million (14.4%) beneficiaries had a claim for a service and/or treatment for any dementia subtype. Dementia not otherwise specified was the most common diagnosis (present in 92.9%). The most common subtype was Alzheimer's (43.5%), followed by vascular (14.5%), Lewy body (5.4%), frontotemporal (1.0%), and alcohol induced (0.7%). The prevalence of other types of diagnosed dementia was 0.2%.

DISCUSSION:

This study is the first to document concurrent prevalence of primary dementia subtypes among this US population. The findings can assist in prioritizing dementia research, clinical services, and caregiving resources.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 8_ODS3_consumo_sustancias_psicoactivas Base de dados: MEDLINE Assunto principal: Medicare / Planos de Pagamento por Serviço Prestado / Demência Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male País/Região como assunto: America do norte Idioma: En Revista: Alzheimers Dement Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 8_ODS3_consumo_sustancias_psicoactivas Base de dados: MEDLINE Assunto principal: Medicare / Planos de Pagamento por Serviço Prestado / Demência Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male País/Região como assunto: America do norte Idioma: En Revista: Alzheimers Dement Ano de publicação: 2017 Tipo de documento: Article